Materialise (MTLS) Q2 FY26 earnings call

Materialise delivered a robust second quarter, marked by significant profitability expansion and strategic portfolio adjustments. The company saw strong growth in its Medical segment and improved operating performance in Manufacturing, while the Software segment faced headwinds from cautious customer spending. Management raised its full-year adjusted EBIT guidance, reflecting confidence in execution and cost discipline, as it continues to focus on core growth segments and digital transformation.